Several labs have shown that EP4 is upregulated in malignant cells with stem-like properties and that treatment of tumor-bearing mice with EP4 antagonists (RQ15986, AH23848, Frondoside A) reduces the number of CSC (Kundu et al., 2014; Majumder et al., 2014). This evidence concerns the gene PTGER4 and neoplasm.